Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS.
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Letter to the Editor: Trigeminal neuralgia in patients with multiple sclerosis.
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study.
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
MRI in multiple sclerosis: what's inside the toolbox?
The Characteristics of Multiple Sclerosis in Iran.
Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.
Gray matter imaging in multiple sclerosis: what have we learned?
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
Disappearing MS T2 lesions may have persistent tissue injury by diffusion tensor and magnetisation transfer imaging
MRI monitoring of spinal cord changes in patients with multiple sclerosis.
Is progressive multiple sclerosis a gray matter disease?
MRI as an outcome in multiple sclerosis clinical trials.
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Disability as an outcome in MS clinical trials.
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.
Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.
Development of a central nervous system axonal myelination assay for high throughput screening.
The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands.
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »